Mind matters in cancer survival

Psycho-Oncology

Volumn 21, Issue 6, 2012, Pages 588-593

  Spiegel, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; cytokine; endocrine; group therapy; psychotherapy; survival

Indexed keywords

ANGIOGENIC FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CIRCADIAN RHYTHM; DEPRESSION; GENE EXPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; METASTASIS; MORTALITY; PSYCHOLOGICAL ASPECT;

CIRCADIAN RHYTHM; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEOPLASMS; PITUITARY-ADRENAL SYSTEM; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SALIVA; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SURVIVORS;

EID: 84861817848     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3067     Document Type: Article

References (76)

1. House JS, Landis KR, Umberson D,. Social relationships and health. Science 1988; 241: 540-545.
2. Reynolds P, Kaplan GA,. Social connections and risk for cancer: prospective evidence from the Alameda County Study. Behav Med 1990; 16: 101-110.
3. Phillips DP, Van Voorhees CA, Ruth TE,. The birthday: lifeline or deadline? Psychosom Med 1992; 54: 532-542.
4. Phillips DP, Ruth TE, Wagner LM,. Psychology and survival [see comments]. Lancet 1993; 342: 1142-1145.
5. Penninx BW,. Chronically depressed mood and cancer risk in older persons. [see comments.]. J Natl Cancer Inst 1998; 90: 1888-1893.
6. Giese-Davis J, Collie K, Rancourt KM, et al,. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011; 29: 413-420.
7. Spiegel D,. Mind matters in cancer survival. JAMA 2011; 305: 502-503.
8. Temel JS, Greer JA, Muzikansky A, et al,. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
9. Spiegel D, Glafkides MC,. Effects of group confrontation with death and dying. Int J Group Psychother 1983; 33: 433-447.
10. Spiegel D, Bloom JR, Yalom I,. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 1981; 38: 527-533.
11. Spiegel D, Bloom JR,. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983; 45: 333-339.
12. Spiegel D, Butler LD, Giese-Davis J, et al,. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 2007; 110: 1130-1138.
13. Peto R, Boreham J, Clarke M, et al,. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000; 355: 1822.
14. Andersen BL, Yang HC, Farrar WB, et al,. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 2008; 113: 3450-3458.
15. Andersen BL, Thornton LM, Shapiro CL, et al,. Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Res 2010; 16: 3270-3278.
16. Spiegel D, Bloom JR, Kraemer HC, et al,. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888-891.
17. Fawzy F, Fawzy N, Hyun C, et al,. Malignant melanoma: effects of an early structural psychiatric intervention, coping and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681-689.
18. Kuchler T, Bestmann B, Rappat S, et al,. Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. J Clin Oncol 2007; 25: 2702-2708.
19. Kuchler T, Henne-Bruns D, Rappat S, et al,. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 1999; 46: 322-335.
20. Richardson JL, Shelton DR, Krailo M, et al,. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990; 8: 356-364.
21. McCorkle R, Strumpf NE, Nuamah IF, et al,. A specialized home care intervention improves survival among older post-surgical cancer patients. [see comments.]. J Am Geriatr Soc 2000; 48: 1707-1713.
22. Linn MW, Linn BS, Harris R,. Effects of counseling for late stage cancer. Cancer 1982; 49: 1048-1055.
23. Ilnyckyj A, Farber J, Cheang M, et al,. A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Physicians Surg Can 1994; 27: 93-96.
24. Cunningham AJ, Edmonds CVI, Jenkins GP, et al,. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-Oncology 1998; 7: 508-517.
25. Edelman S, Lemon J, Bell DR, et al,. Effects of group CBT on the survival time of patients with metastatic breast cancer. Psycho-Oncology 1999; 8: 474-481.
26. Goodwin PJ, Leszcz M, Ennis M, et al,. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001; 345: 1719-1726.
27. Kissane DW, Grabsch B, Clarke DM, et al,. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology 2007; 16: 277-286.
28. Spiegel D,. Effects of psychotherapy on cancer survival. Nat Rev Cancer 2002; 2: 383-389.
29. Spiegel D,. A 43-year-old woman coping with cancer. [see comments.]. JAMA 1999; 282: 371-378.
30. Kiecolt-Glaser JK, Glaser R,. Psychoneuroimmunology and cancer: fact or fiction? Eur J Cancer 1999; 35: 1603-1607.
31. Antonijevic IA,. Depressive disorders-is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006; 31: 1-15.
32. Riley V,. Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 1975; 189: 465-467.
33. Riley V,. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981; 212: 1100-1109.
34. McEwen BS,. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171-179.
35. Sapolsky RM, Donnelly TM,. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 1985; 117: 662-666.
36. Sapolsky R, Krey L, McEwen BS,. Prolonged glucocorticoidexposure reduces hippocampal neuron number: implication for aging. J Neurosci 1985; 5: 1222-1227.
37. Jayo JM, Shively CA, Kaplan JR, et al,. Effects of exercise and stress on body fat distribution in male cynomolgus monkeys. Int J Obes Relat Metab Disord 1993; 17: 597-604.
38. Epel E, McEwen B, Seeman T, et al,. Psychological stress and lack of cortisol habituation among women with abdominal fat distribution. Psychosom Med 1999; 61: 107.
39. Plotsky PM, Owens MJ, Nemeroff CB,. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21: 293-307.
40. Posener JA, Schildkraut JJ, Samson JA, et al,. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology 1996; 21: 33-38.
41. Sapolsky RM, Krey LC, McEwen BS,. The adrenocortical stress-response in the aged male rat: impairment of recovery from stress. Exp Gerontol 1983; 18: 55-64.
42. Yehuda R, Southwick SM, Krystal JH, et al,. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 1993; 150: 83-86.
43. Yehuda R, Teicher MH, Trestman RL, et al,. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 1996; 40: 79-88.
44. Alter CL, Pelcovitz D, Axelrod A, et al,. Identification of PTSD in cancer survivors. Psychometrics 1996; 37: 137-143.
45. Malt UF, Tjemsland L,. PTSD in women with breast cancer. Psychosomatics 1999; 40: 89.
46. Andrykowski MA, Cordova MJ, McGrath PC, et al,. Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psycho-Oncology 2000; 9: 69-78.
47. Cordova MJ, Andrykowski MA, Kenady DE, et al,. Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. J Consult Clin Psychol 1995; 63: 981-986.
48. Ben-Eliyahu S, Yirmiya R, Liebeskind JC, et al,. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 1991; 5: 193-205.
49. Spiegel D,. Psychological distress and disease course for women with breast cancer: one answer, many questions. J Natl Cancer Inst 1996; 88: 629-631.
50. Spiegel D,. Healing words: emotional expression and disease outcome [editorial; comment]. JAMA 1999; 281: 1328-1329.
51. Palesh O, Butler LD, Koopman C, et al,. Stress history and breast cancer recurrence. J Psychosom Res 2007; 63: 233-239.
52. Sheridan JF, Dobbs C, Jung J, et al,. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann N Y Acad Sci 1998; 840: 803-808.
53. Sheridan JF,. Stress-induced modulation of anti-viral immunity-Normal Cousins Memorial Lecture 1997. Brain Behav Immun 1998; 12: 1-6.
54. Padgett DA, Loria RM, Sheridan JF,: Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J Neuroimmunol 1997; 78: 203-211.
55. Glaser R, Kiecolt-Glaser JK,. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 1998; 105: 35S-42S.
56. Kiecolt-Glaser JK, Glaser R, Cacioppo JT, et al,. Marital stress: immunologic, neuroendocrine, and autonomic correlates. Ann N Y Acad Sci 1998; 840: 656-663.
57. Cohen S, Tyrrell DA, Smith AP,. Psychological stress and susceptibility to the common cold [see comments]. N Engl J Med 1991; 325: 606-612.
58. Baltrusch HJ, Stangel W, Titze I,. Stress, cancer and immunity. New developments in biopsychosocial and psychoneuroimmunologic research. Acta Neurol (Napoli) 1991; 13: 315-327.
59. Levy SM, Herberman RB, Maluish AM, et al,. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 1985; 4: 99-113.
60. Head JF, Elliott RL, McCoy JL,. Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Res Treat 1993; 26: 77-88.
61. Andersen BL, Farrar WB, Golden-Kreutz D, et al,. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 1998; 90: 30-36.
62. Abercrombie HC, Giese-Davis J, Sephton S, et al,. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 2004; 29: 1082-1092.
63. Sephton SE, Sapolsky RM, Kraemer HC, et al,. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000; 92: 994-1000.
64. Lu H, Ouyang W, Huang C,. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4: 221-233.
65. Spiegel D, Giese-Davis J, Taylor CB, et al,. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 2006; 31: 1231-1244.
66. Yirmiya R, Pollak Y, Morag M, et al,. Illness, cytokines, and depression. Ann N Y Acad Sci 2000; 917: 478-487.
67. Maes M, Bosmans E, Meltzer HY,. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 1995; 245: 172-178.
68. Maes M,. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999; 461: 25-46.
69. Raison CL, Borisov AS, Woolwine BJ, et al,. Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 2010; 15 (5): 535-547.
70. Antonova L, Mueller CR,. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosomes Cancer 2008; 47: 341-352.
71. Raison CL, Miller AH,. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003; 54: 283-294.
72. Sood AK, Lutgendorf SK,. Stress influences on anoikis. Canc Prev Res 2011; 4: 481-485.
73. Lutgendorf SK, DeGeest K, Dahmoush L, et al,. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 2011; 25: 250-255.
74. Barron TI, Connolly RM, Sharp L, et al,. Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol 2011; 29: 2635-2644.
75. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, et al,. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 2011; 29: 2645-2652.
76. Powe DG, Voss MJ, Zanker KS, et al,. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 2010; 1: 628-638.